12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Horizon Pharma, Mundipharma sales and marketing update

The companies added 17 territories to their 2010 deal granting Mundipharma exclusive rights to commercialize Lodotra prednisone in Australia, China, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, South Africa, Taiwan, Thailand and Vietnam. The territories...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >